Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07910747Not yet recruiting
Randomised, double-blind trial in obesity and inflammation (6 arms), sponsored by Universidade de São Paulo. Primary endpoint: Changes in diurnal variation of BMAL1 gene expression in peripheral blood mononuclear cells (PBMCs) at 12 weeks. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07910747.